Figure 1.
Cumulative incidence of venous thromboembolism of pancreatic cancer patients with different levels of active plasminogen activator inhibitor 1. Low levels (dashed line) defined as patients with active PAI-1 levels below the median; high levels (solid line) defined as active PAI-1 levels at or above the median.

Cumulative incidence of venous thromboembolism of pancreatic cancer patients with different levels of active plasminogen activator inhibitor 1. Low levels (dashed line) defined as patients with active PAI-1 levels below the median; high levels (solid line) defined as active PAI-1 levels at or above the median.

Close Modal

or Create an Account

Close Modal
Close Modal